Evidence map›Paper›PMID 41773119›Full record

ArticleCureus2026

Stereotactic Body Radiation Therapy in the Management of Recurrent Unresectable Retroperitoneal Ganglioneuroma.

Bradley Callas, Shyam Jani, Isheeta S Govardhan, Nitika Thawani, Shyamal Patel

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bradley CallasSchool of Medicine, Creighton University School of Medicine, Phoenix, USA.
Shyam JaniDepartment of Radiation Oncology/Medical Physics, St. Joseph's Hospital and Medical Center, Phoenix, USA.
Isheeta S GovardhanDepartment of Surgery, Creighton University School of Medicine, Phoenix, USA.
Nitika ThawaniDepartment of Radiation Oncology, St. Joseph's Hospital and Medical Center, Phoenix, USA.
Shyamal PatelDepartment of Radiation Oncology, St. Joseph's Hospital and Medical Center, Phoenix, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ganglioneuromas are rare, benign tumors arising from neural crest cells, typically managed with surgical resection. We present a unique case of a 35-year-old man with a history of ganglioneuroma resected in early childhood, who developed a recurrent retroperitoneal mass more than 30 years later. Imaging revealed a 12 cm lesion encasing critical structures, rendering it surgically unresectable. The patient underwent stereotactic body radiotherapy (SBRT), receiving 40 Gy in five fractions using volumetric modulated arc therapy (VMAT). Treatment was well-tolerated with no significant toxicity. Follow-up imaging over two years demonstrated stable disease without progression or symptom recurrence. To our knowledge, this is the first reported case of SBRT utilized for a retroperitoneal ganglioneuroma, highlighting its potential as a noninvasive alternative in cases where surgery is contraindicated. This case underscores the importance of long-term surveillance in patients with previously resected ganglioneuromas and suggests that SBRT may be a viable treatment option when surgical intervention poses significant risks.

Indexed as

clinical case reportganglioneuromaneurogenic tumorradiation oncology and clinical oncologyretroperitoneal massstereotactic body radiotherapy (sbrt)targeted radiation therapyunresectable ganglioneuroma

Identifiers

PMID41773119
PMCPMC12950179

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.